Heart Valve Diseases: Clinical Trials

2,679 trials for Heart Valve Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1047 completed, 511 unknown, 507 recruiting, 192 active not recruiting. 1114 Not applicable, 134 Phase 4, 124 Phase 2, 101 Phase 3, 51 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1114Completed 410, Unknown 199, Recruiting 197, Active not recruiting 112, Not yet recruiting 80, Terminated 65, Withdrawn 33, Enrolling by invitation 15, Suspended 3
Phase 4134Completed 53, Unknown 35, Recruiting 20, Not yet recruiting 9, Terminated 9, Withdrawn 3, Active not recruiting 2, Enrolling by invitation 2, Suspended 1
Phase 2124Completed 57, Unknown 20, Terminated 16, Recruiting 13, Withdrawn 6, Active not recruiting 4, Not yet recruiting 4, Suspended 3, Enrolling by invitation 1
Phase 3101Completed 45, Unknown 16, Terminated 14, Active not recruiting 8, Recruiting 8, Not yet recruiting 5, Withdrawn 3, Enrolling by invitation 1, Suspended 1
Phase 151Completed 32, Unknown 8, Terminated 5, Recruiting 4, Withdrawn 2
Early Phase 18Completed 5, Withdrawn 2, Not yet recruiting 1

Follow Heart Valve Diseases: new trials by email Literature Review of Heart Valve Diseases trials Research Report on Heart Valve Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Categorizing Patient Risk for Tricuspid Regurgitation (TR) Intervention With Admittance Pulmonary Artery Catheter System (APACS)
Right Heart Catheterization - Tricuspid Regurgitation (TR)
Not yet recruitingFeldman Cardiology, PLLC82027-07-102026-03-30
Aficamten and Patient-Reported Outcomes in Real-World nHCM
receiving aficamten - Hypertrophic Cardiomyopathy (HCM)
Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine1002027-06-012026-09-29
Understanding the Metabolic and Functional Derangement of Primary Mitral Regurgitation: a Feasibility Study Using Carbon 11(C-11) Acetate Cardiac Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI)
[11C] acetate - Mitral Valve Regurgitation
Early Phase 1WithdrawnUniversity of Alabama at Birmingham2027-06-012025-01-24
A Clinical Study of X-Clip Mitral Valve Clip System and Steerable Guide System for Transcatheter Mitral Valve Repair of Degenerative Mitral Regurgitation
X-Clip Treatment for Degenerative Mitral Regurgitation - Transcatheter Mitral Valve Repair of Degenerative Mitral Regurgitation
Not applicableNot yet recruitingShenzhen Lifevalve Medical Scientific Co., Ltd.152027-03-012026-06-22
Improving Management and Secondary Prevention Through Azithromycin Comparative Trial in Rheumatic Heart Disease in Nigeria)- IMPACT-RHD Nigeria
Benzathine Penicillin, Azithromycin (Azithro) - Rheumatic Fever, Valvular Heart Diseases
Not applicableNot yet recruitingLadoke Akintola University of Technology, Ogbomoso, Nigeria4742027-01-052026-06-04
Evaluation of a Management Algorithm for TAVI Patients With Concomitant Mitral or Tricuspid Regurgitation
Aortic Stenosis, Mitral Regurgitation
Not yet recruitingJosep Rodes-Cabau3002027-01-052026-11-04
High Flow Nasal Oxygenation in Transcatheter Aortic Valve Replacement Procedures. TAVR-Highflow II
Oxygen therapy during sedation provided via high nasal cannulae (60L/min at 60% FiO2), Oxygen therapy during sedation delivered via nasal cannulae at 5L/min - Aortic Stenosis Treated With TAVI, Sedation; Aged; Hemodynamics
Not applicableNot yet recruitingHospital Clinic of Barcelona4522027-01-012026-09-18
Biventricular Remodeling in Transcatheter Tricuspid Valve Replacement - Acute Hemodynamic Instability Study
Tricuspid Regurgitation, Heart Failure
Enrolling by invitationColumbia University1402027-01-012026-02-12
ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral
SAPIEN X4 THV - Mitral Regurgitation, Mitral Valve Disease
Not applicableNot yet recruitingEdwards Lifesciences1252027-01-012025-12-22
Assessment of Transnational Performance of the Universal Cardiac Surgical Risk Score Across International Sites
Risk score calculation - Heart Valve Diseases, Cardiac Surgical Procedures
Not yet recruitingUnion Health System50002027-01-012026-11-05
TRI-SUCCESS - Tricuspid Regurgitation Study of the Unica™ Cross-Caval System for the Evaluation of Efficacy and Safety in Significant TR Subjects
Innoventric Unica™ System - Tricuspid Regurgitation, Tricuspid Regurgitation Functional
Not applicableNot yet recruitingInnoventric LTD5102027-01-012026-11-05
A Study to Evaluate the Safety and Efficacy of Mavacamten in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (SOLSTICE-HCM)
Mavacamten, Placebo - Non-obstructive Hypertrophic Cardiomyopathy
Phase 3Not yet recruitingBristol-Myers Squibb5002026-12-292026-11-17
Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE)
Kosmos Torso-One AI-guided Point-of-Care Ultrasound (EchoNous, Inc.) - Valvular Heart Disease Patients, Aortic Stenosis
Not applicableNot yet recruitingUniversity of Texas Southwestern Medical Center10882026-12-152026-11-03
A Prospective, Multi-centre, Single Arm, Pivotal Clinical Study to Determine the Safety and Effectiveness of Crea Aortic Valve for Use as a Replacement Aortic Heart Valve
Investigational Transcatheter Aortic Valve Replacement System - Aortic Valve Stenosis, Severe Aortic Stenosis
Not applicableNot yet recruitingOnecrea Medical Inc.302026-12-042026-07-29
Gradual Tapering or Discontinuation of Beta-Blockers After Stabilization With Mavacamten Therapy
Beta-Blocker Sequential Tapering and Discontinuation, Beta-Blocker Baseline Stable-Dose Maintenance - Obstructive Hypertrophic Cardiomyopathy (oHCM)
Not applicableNot yet recruitingFirst Affiliated Hospital of Wenzhou Medical University2862026-12-012026-09-11
Regression in Left Ventricular Hypertrophy and Fibrosis in Aortic Stenosis
Dapagliflozin (DAPA), Spironolactone (drug), Spironolactone + Dapagliflozin - Aortic Stenosis
Phase 2Not yet recruitingUniversity College, London4452026-12-012026-09-11
Effect of Double-Tap Optimization on Valve Expansion and Hemodynamics in Balloon-expandable Transcatheter Aortic Valve Implantation: A Randomized Clinical Trial (DO-OPT TAVI Trial)
Double-Tap Balloon Post-dilatation, Conventional Single-Inflation TAVI - Severe Aortic Stenosis
Not applicableNot yet recruitingYonsei University2502026-12-012026-11-03
Application of TAVI at Experienced Interventional Cardiac Centers Without On-site Cardiac Surgery (ATLAS Study)
Transcatheter Aortic Valve Replacement (TAVR) with surgical oversight, Transcatheter Aortic Valve Replacement (TAVR) without surgical oversight - Aortic Stenosis, Severe Aortic Stenosis
Phase 4Not yet recruitingUniversity of Alberta6002026-12-012026-10-27
Sparrow App Guided Evaluation (SAGE) Vanguard Trial for Aortic Stenosis in Adults Aged Seventy and Older
Stethophone - Moderate or Severe Aortic Stenosis
Not applicableNot yet recruitingSunnybrook Health Sciences Centre10002026-12-012026-11-12
NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices
SESAME Procedure - Hypertrophic Cardiomyopathy, Left Ventricular Outflow Obstruction
Not applicableNot yet recruitingNational Heart, Lung, and Blood Institute (NHLBI)2002026-11-222026-11-17

Showing 20 of 2679. Sign in to see all of them.

Narrower conditions

Aortic Valve Stenosis (992)  ·  Mitral Valve Insufficiency (433)  ·  Cardiomyopathy, Hypertrophic (354)  ·  Aortic Valve Disease (227)  ·  Tricuspid Valve Insufficiency (215)  ·  Heart Failure (181)  ·  Coronary Artery Disease (170)  ·  Aortic Valve Insufficiency (166)  ·  Cardiovascular Diseases (127)  ·  Heart Diseases (104)  ·  Atrial Fibrillation (75)  ·  Bicuspid Aortic Valve Disease (62)  ·  Mitral Valve Stenosis (62)  ·  Cardiomyopathies (50)

Broader conditions

Heart Diseases (2575)  ·  Cardiovascular Diseases (2552)  ·  Aortic Valve Disease (1413)  ·  Ventricular Outflow Obstruction (1026)  ·  Pathological Conditions, Signs and Symptoms (431)  ·  Vascular Diseases (401)  ·  Aortic Valve Stenosis (387)  ·  Aortic Stenosis, Subvalvular (355)  ·  Cardiomyopathies (332)  ·  Pathologic Processes (317)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (270)  ·  Myocardial Ischemia (207)  ·  Congenital Abnormalities (202)  ·  Arterial Occlusive Diseases (180)

Interventions

Transcatheter Aortic Valve Replacement (159)  ·  MYK-461 (38)  ·  Echocardiography (32)  ·  Mitral Valve Annuloplasty (25)  ·  Warfarin (20)  ·  Blood Specimen Collection (17)  ·  Aspirin (15)  ·  Exercise (14)  ·  Metoprolol (13)  ·  Sodium Chloride (13)  ·  Clopidogrel (12)  ·  Saline Solution (12)  ·  Propofol (11)  ·  Magnetic Resonance Imaging (10)  ·  Replantation (10)

Sponsors

Edwards Lifesciences (99)  ·  Abbott Medical Devices (69)  ·  National Heart, Lung, and Blood Institute (NHLBI) (43)  ·  Medtronic Cardiovascular (31)  ·  China National Center for Cardiovascular Diseases (27)  ·  Bristol-Myers Squibb (26)  ·  Xijing Hospital (25)  ·  Assiut University (23)  ·  Mayo Clinic (23)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (20)  ·  Yonsei University (20)  ·  Chinese Academy of Medical Sciences, Fuwai Hospital (19)  ·  Institut für Pharmakologie und Präventive Medizin (18)  ·  Assistance Publique - Hôpitaux de Paris (17)  ·  Boston Scientific Corporation (17)

Countries

United States (614)  ·  Germany (393)  ·  China (281)  ·  France (275)  ·  Italy (274)  ·  United Kingdom (230)  ·  Canada (206)  ·  Netherlands (182)  ·  Spain (160)  ·  Switzerland (129)  ·  Denmark (121)  ·  Belgium (99)  ·  South Korea (90)  ·  Poland (84)  ·  Austria (80)

Top investigators

Vinod Thourani, MD (10)  ·  Robert J Lederman, M.D. (8)  ·  Hendrik Treede, MD (7)  ·  Susheel Kodali, MD (7)  ·  Barathi Sethuraman (6)  ·  John Webb, MD (6)  ·  Martin B Leon, MD (6)  ·  Azeem Latib, MD (5)  ·  Mayra Guerrero, MD (5)  ·  Michael Reardon, MD (5)  ·  Duk-Hyun Kang, M.D. (4)  ·  Gorav Ailawadi, MD (4)

Results publications

PMID 20961243, PMID 33962483, PMID 21639811, PMID 29555836, PMID 31690104, PMID 31883339, PMID 35041482, PMID 38710669, PMID 42636950, PMID 12831818, PMID 24678937, PMID 25593120, PMID 27040324, PMID 30586701, PMID 31525069, PMID 32774184, PMID 34581194, PMID 35321859, PMID 35595203, PMID 35656983, PMID 36515976, PMID 40392571, PMID 41251714, PMID 16980116, PMID 20096533, PMID 20188503, PMID 20566953, PMID 21273254, PMID 21422390, PMID 21492763, PMID 22424519, PMID 22443479, PMID 23349346, PMID 23633132, PMID 24621999, PMID 24657695, PMID 25011722, PMID 25500293, PMID 25533774, PMID 25655063, PMID 25788234, PMID 26139739, PMID 26384204, PMID 26436963, PMID 26491110, PMID 26896466, PMID 27601429, PMID 27609682, PMID 27777294, PMID 27815101

NIH funding

2023 (10), U01HL088942 (9), 2019 (7), 2018 (4), 2025 (4), 2015 (3), 2016 (2), 2017 (2), R01AG089981 (2), R21HL150373 (2), 1RC1LM010526 (1), 2009 (1), 2014 (1), 268201000048C-5-0-1 (1), 595 (1)